Multicenter evaluation of the MicroScan Rapid Gram-Negative Identification Type 3 Panel.
Bascomb S, Abbott SL, Bobolis JD, Bruckner DA, Connell SJ, Cullen SK, Daugherty M, Glenn D, Janda JM, Lentsch SJ, Lindquist D, Mayhew PB, Nothaft DM, Skinner JR, Williams GB, Wong J, Zimmer BL.
Bascomb S, et al.
J Clin Microbiol. 1997 Oct;35(10):2531-6. doi: 10.1128/jcm.35.10.2531-2536.1997.
J Clin Microbiol. 1997.
PMID: 9316902
Free PMC article.
Clinical Trial.
A total of 405 fresh and stock gram-negative isolates comprising 54 species were tested in the efficacy phase; 96.8% of these species were identified correctly in comparison to the identification obtained either with the API 20E system (bioMerieux Vitek, Hazelwood, Mo.) or …
A total of 405 fresh and stock gram-negative isolates comprising 54 species were tested in the efficacy phase; 96.8% of these species were i …